| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.2 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.21 | 0.2 |